Presentations

Andreu, Georges (1) Haemovigilance in optimal use of blood components

Bregeon, Thomas What to report to the EU comission

Caldani, Cyril Reporting of SAr and SAE in France

de Vries, Rene EHN: aims and objectives

Fehily, Deirdre The EUSTITE project

Fernandez-Zincke, E EU blood and tissues directives

Franklin, Ian EU optimal blood use project

Greinacher, Andreas Are banked RBC concentrates dangerous

Heiden, Margarethe The transfusion system in Germany

Hudson, Patrick Risk management in the hospital environment

Jorgensen, Jan Haemovigilance and blood donation

Keller-Stanislawski, B Haemovigilance vs. pharmacovigilance in Germany

Kirste, Guenter Safety of organs in Europe

Kuehnert, Matthew Progress on biovigilance

Lawlor, Emer Overtransfusion

Ljungman, Per G-CSF use in healthy stem cell donors

Mayer, B Iron depletion in whole blood donors

Muylle, Ludo (1) Feedback on workshop on EU directives

Muylle, Ludo (2) SAE definitions in blood establishments

Noel, Luc Vigilance of human stem cells and tissues

Okazaki, Hitoshi Donor vigilance in Japan

Robillard, Pierre (1) Transfusion errors and their prevention

Robillard, Pierre (2) Overview of principal models of haemovigilance

Schrezenmeier, Hubert Risk of apheresis vs. whole blood donoation

Seitz, Rainer Perception of blood safety in Europe

Spannagl, M Prevention and treatment of major blood loss

Strengers, Paul What kind of risk is acceptable for drugs?

Taylor, Clare SHOT – the hidden data

Taylor, Clare (2) reporting SAR and SAE – the UK experience

Tomasulo, Peter Donor AEs and possible interventions

van der Poel, Cees Donor epidemiology

Wallis, Jonathan (1) Uses and adverse effects of erythropoietin

Wallis, Jonathan (2) Transfusion epidemiology

Wells, Angus Epidemiology and survival of transfusion recipients (EASTR)

Wiersum-Osselton, Jo (1) How many serious transfusion reactions can be prevented

Wiersum-Osselton, Jo (2) Reporting SARs and SAES from cells and tissues in the Netherlands

Pages